{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:04:08Z","timestamp":1789473848338,"version":"build-2803163510"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Protease-activated receptor (PAR) 1 and PAR2 have been implicated in RA, however their exact role is unclear. Here, we detailed the mechanistic impact of these receptors on the onset and development of inflammatory arthritis in murine CIA and antigen-induced arthritis (AIA) models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>CIA or AIA was induced in PAR1 or PAR2 gene knockout (KO) and matched wild type mice. The onset and development of arthritis was monitored clinically and histologically. Immune cells, cytokines and MMPs were detected by ELISA, zymography, flow cytometry, western blot or immunohistochemistry.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In CIA, PAR1KO and PAR2KO exacerbated arthritis, in opposition to their effects in AIA. These deficient mice had high plasma levels of IL-17, IFN-\u03b3, TGF-\u03b21 and MMP-13, and lower levels of TNF-\u03b1; T cells and B cells were higher in both KO spleen and thymus, and myeloid-derived suppressor cells were lower only in PAR1KO spleen, when compared with wild type cells. Th1, Th2 and Th17 cells were lower in PAR1KO spleens cells, whereas Th1 and Th2 cells were lower and Th17 cells higher in both KO thymus cells, when compared with wild type cells. PAR1KO synovial fibroblasts proliferated faster and produced the most abundant MMP-9 amongst three type cells in the control, lipopolysaccharides or TNF stimulated conditions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This is the first study demonstrated that deficiency of PAR1 or PAR2 aggravates inflammatory arthritis in CIA. Furthermore, the protective functions of PAR1 and PAR2 in CIA likely occur via differing mechanisms involving immune cell differentiation and cytokines\/MMPs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa701","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T12:17:30Z","timestamp":1602591450000},"page":"2990-3003","source":"Crossref","is-referenced-by-count":15,"title":["Deficiency of protease-activated receptor (PAR) 1 and PAR2 exacerbates collagen-induced arthritis in mice via differing mechanisms"],"prefix":"10.1093","volume":"60","author":[{"given":"Meilang","family":"Xue","sequence":"first","affiliation":[{"name":"Sutton Arthritis Research Laboratory, Institute of Bone and Joint Research, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Lin","sequence":"additional","affiliation":[{"name":"Sutton Arthritis Research Laboratory, Institute of Bone and Joint Research, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai Po Helena","family":"Liang","sequence":"additional","affiliation":[{"name":"Sutton Arthritis Research Laboratory, Institute of Bone and Joint Research, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"McKelvey","sequence":"additional","affiliation":[{"name":"Bill Walsh Translational Cancer Research Laboratory, Kolling Institute of Medical Research, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Sutton Arthritis Research Laboratory, Institute of Bone and Joint Research, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyn","family":"March","sequence":"additional","affiliation":[{"name":"Sutton Arthritis Research Laboratory, Institute of Bone and Joint Research, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Jackson","sequence":"additional","affiliation":[{"name":"Sutton Arthritis Research Laboratory, Institute of Bone and Joint Research, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"key":"2021070723585572000_keaa701-B1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/art.33323","article-title":"Protease-activated receptor 2, rather than protease-activated receptor 1, contributes to the aggressive properties of synovial fibroblasts in rheumatoid arthritis","volume":"64","author":"Xue","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2021070723585572000_keaa701-B2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/art.22423","article-title":"Expression and proinflammatory role of proteinase-activated receptor 2 in rheumatoid synovium: ex vivo studies using a novel proteinase-activated receptor 2 antagonist","volume":"56","author":"Kelso","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2021070723585572000_keaa701-B3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1478-811X-11-86","article-title":"Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact","volume":"11","author":"Gieseler","year":"2013","journal-title":"Cell Commun Signal"},{"key":"2021070723585572000_keaa701-B4","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.4049\/jimmunol.165.11.6504","article-title":"Delayed onset of inflammation in protease-activated receptor-2-deficient mice","volume":"165","author":"Lindner","year":"2000","journal-title":"J Immunol"},{"key":"2021070723585572000_keaa701-B5","doi-asserted-by":"crossref","first-page":"L368","DOI":"10.1152\/ajplung.00036.2007","article-title":"Role of PAR2 in murine pulmonary pseudomonal infection","volume":"294","author":"Moraes","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2021070723585572000_keaa701-B6","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI66125","article-title":"PAR-1 contributes to the innate immune response during viral infection","volume":"123","author":"Antoniak","year":"2013","journal-title":"J Clin Invest"},{"key":"2021070723585572000_keaa701-B7","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"2021070723585572000_keaa701-B8","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3390\/cells8070700","article-title":"Mucosa-environment interactions in the pathogenesis of rheumatoid arthritis","volume":"8","author":"Lucchino","year":"2019","journal-title":"Cells"},{"key":"2021070723585572000_keaa701-B9","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.biocel.2007.12.003","article-title":"Protease-activated receptors in the musculoskeletal system","volume":"40","author":"Mackie","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"2021070723585572000_keaa701-B10","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/annrheumdis-2011-200703","article-title":"PAR2 expression in peripheral blood monocytes of patients with rheumatoid arthritis","volume":"71","author":"Crilly","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2021070723585572000_keaa701-B11","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/art.21001","article-title":"Reduction of arthritis severity in protease-activated receptor-deficient mice","volume":"52","author":"Yang","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2021070723585572000_keaa701-B12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/art.22312","article-title":"Evaluation of protease-activated receptor 2 in murine models of arthritis","volume":"56","author":"Busso","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2021070723585572000_keaa701-B13","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/1521-4141(200006)30:6<1568::AID-IMMU1568>3.0.CO;2-R","article-title":"Collagen-induced arthritis in C57BL\/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis","volume":"30","author":"Campbell","year":"2000","journal-title":"Eur J Immunol"},{"key":"2021070723585572000_keaa701-B14","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1002\/1529-0131(200111)44:11<2697::AID-ART450>3.0.CO;2-#","article-title":"Amelioration of arthritis in two murine models using antibodies to oncostatin M","volume":"44","author":"Plater-Zyberk","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2021070723585572000_keaa701-B15","doi-asserted-by":"crossref","first-page":"R44","DOI":"10.1186\/ar4473","article-title":"Endothelial protein C receptor-associated invasiveness of rheumatoid synovial fibroblasts is likely driven by group V secretory phospholipase A2","volume":"16","author":"Xue","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2021070723585572000_keaa701-B16","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1016\/S0021-9258(17)35860-X","article-title":"Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors","volume":"261","author":"Herron","year":"1986","journal-title":"J Biol Chem"},{"key":"2021070723585572000_keaa701-B17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1172\/JCI16913","article-title":"Essential role for proteinase-activated receptor-2 in arthritis","volume":"111","author":"Ferrell","year":"2003","journal-title":"J Clin Invest"},{"key":"2021070723585572000_keaa701-B18","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1158\/1078-0432.CCR-15-2240","article-title":"Molecular pathways: revisiting glycogen synthase kinase-3 beta as a target for the treatment of cancer","volume":"23","author":"Walz","year":"2017","journal-title":"Clin Cancer Res"},{"key":"2021070723585572000_keaa701-B19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1385\/MB:31:2:151","article-title":"The ERK cascade: a prototype of MAPK signaling","volume":"31","author":"Rubinfeld","year":"2005","journal-title":"Mol Biotechnol"},{"key":"2021070723585572000_keaa701-B20","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2741\/2161","article-title":"The dual personalities of matrix metalloproteinases in inflammation","volume":"12","author":"Le","year":"2007","journal-title":"Front Biosci"},{"key":"2021070723585572000_keaa701-B21","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1136\/annrheumdis-2011-200869","article-title":"Immunomodulatory role of proteinase-activated receptor-2","volume":"71","author":"Crilly","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2021070723585572000_keaa701-B22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fendo.2018.00257","article-title":"Rheumatic disease: protease-activated receptor-2 in synovial joint pathobiology","volume":"9","author":"McCulloch","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2021070723585572000_keaa701-B23","doi-asserted-by":"crossref","first-page":"13936","DOI":"10.1073\/pnas.241377298","article-title":"Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis","volume":"98","author":"Fiorucci","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021070723585572000_keaa701-B24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/1753425910395044","article-title":"Proteinase-activated receptor 2 activation promotes an anti-inflammatory and alternatively activated phenotype in LPS-stimulated murine macrophages","volume":"18","author":"Nhu","year":"2012","journal-title":"Innate Immun"},{"key":"2021070723585572000_keaa701-B25","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/1753425913479984","article-title":"Proteinase-activated receptor-2 modulates human macrophage differentiation and effector function","volume":"19","author":"Steven","year":"2013","journal-title":"Innate Immun"},{"key":"2021070723585572000_keaa701-B26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/MIB.0000000000001045","article-title":"Protease-activated receptor 1 plays a proinflammatory role in colitis by promoting Th17-related immunity","volume":"23","author":"Saeed","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2021070723585572000_keaa701-B27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1053\/j.gastro.2009.08.043","article-title":"Protease-activated receptor-1 down-regulates the murine inflammatory and humoral response to Helicobacter pylori","volume":"138","author":"Wee","year":"2010","journal-title":"Gastroenterology"},{"key":"2021070723585572000_keaa701-B28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/mi.2014.43","article-title":"Protease-activated receptor 1 suppresses Helicobacter pylori gastritis via the inhibition of macrophage cytokine secretion and interferon regulatory factor 5","volume":"8","author":"Chionh","year":"2015","journal-title":"Mucosal Immunol"},{"key":"2021070723585572000_keaa701-B29","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1182\/blood-2017-10-813527","article-title":"Factor VIIa induces anti-inflammatory signaling via EPCR and PAR1","volume":"131","author":"Kondreddy","year":"2018","journal-title":"Blood"},{"key":"2021070723585572000_keaa701-B30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fendo.2014.00067","article-title":"Biased signaling of protease-activated receptors","volume":"5","author":"Zhao","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2021070723585572000_keaa701-B31","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1182\/blood-2012-08-452169","article-title":"Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46","volume":"120","author":"Mosnier","year":"2012","journal-title":"Blood"},{"key":"2021070723585572000_keaa701-B32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cell.2004.12.018","article-title":"PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells","volume":"120","author":"Boire","year":"2005","journal-title":"Cell"},{"key":"2021070723585572000_keaa701-B33","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1128\/iai.60.4.1714-1716.1992","article-title":"Low biological activity of Helicobacter pylori lipopolysaccharide","volume":"60","author":"Muotiala","year":"1992","journal-title":"Infect Immun"},{"key":"2021070723585572000_keaa701-B34","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1086\/386289","article-title":"Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity","volume":"189","author":"Gewirtz","year":"2004","journal-title":"J Infect Dis"},{"key":"2021070723585572000_keaa701-B35","doi-asserted-by":"crossref","first-page":"27215","DOI":"10.1074\/jbc.M114.599712","article-title":"Cathepsin S causes inflammatory pain via biased agonism of PAR2 and TRPV4","volume":"289","author":"Zhao","year":"2014","journal-title":"J Biol Chem"},{"key":"2021070723585572000_keaa701-B36","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1002\/art.20313","article-title":"Elevation of activated protein C in synovial joints in rheumatoid arthritis and its correlation with matrix metalloproteinase 2","volume":"50","author":"Buisson-Legendre","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2021070723585572000_keaa701-B37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrrheum.2018.17","article-title":"Proteinases and their receptors in inflammatory arthritis: an overview","volume":"14","author":"Oikonomopoulou","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"2021070723585572000_keaa701-B38","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/eji.200939578","article-title":"Animal models of rheumatoid arthritis","volume":"39","author":"Asquith","year":"2009","journal-title":"Eur J Immunol"},{"key":"2021070723585572000_keaa701-B39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/jcm6070067","article-title":"The plasticity of Th17 cells in the pathogenesis of rheumatoid arthritis","volume":"6","author":"Kotake","year":"2017","journal-title":"J Clin Med"},{"key":"2021070723585572000_keaa701-B40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat Med"},{"key":"2021070723585572000_keaa701-B41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/cei.13098","article-title":"Driving chronicity in rheumatoid arthritis: perpetuating role of myeloid cells","volume":"193","author":"Alivernini","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"2021070723585572000_keaa701-B42","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/eji.201445036","article-title":"B cells expressing IFN-\u03b3 suppress Treg-cell differentiation and promote autoimmune experimental arthritis","volume":"45","author":"Olalekan","year":"2015","journal-title":"Eur J Immunol"},{"key":"2021070723585572000_keaa701-B43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/6145810","article-title":"Enigma of IL-17 and Th17 cells in rheumatoid arthritis and in autoimmune animal models of arthritis","volume":"2016","author":"Kugyelka","year":"2016","journal-title":"Mediators Inflamm"},{"key":"2021070723585572000_keaa701-B44","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J"},{"key":"2021070723585572000_keaa701-B45","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1189\/jlb.1213633","article-title":"Th17 cells and Tregs: unlikely allies","volume":"95","author":"Chen","year":"2014","journal-title":"J Leukoc Biol"},{"key":"2021070723585572000_keaa701-B46","first-page":"1","article-title":"Induction of tumor necrosis factor (TNF) release from subtypes of T cells by agonists of proteinase activated receptors","volume":"2013","author":"Yang","year":"2013","journal-title":"Mediators Inflamm"},{"key":"2021070723585572000_keaa701-B47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2018.05.016","article-title":"Novel peptide inhibits inflammation by suppressing of protease activated receptor-2","volume":"832","author":"Kim","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"2021070723585572000_keaa701-B48","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.fct.2017.09.027","article-title":"Mold metabolites drive rheumatoid arthritis in mice via promotion of IFN-gamma- and IL-17-producing T cells","volume":"109","author":"Jahreis","year":"2017","journal-title":"Food Chem Toxicol"},{"key":"2021070723585572000_keaa701-B49","doi-asserted-by":"crossref","first-page":"a022236","DOI":"10.1101\/cshperspect.a022236","article-title":"Regulation of the immune response by TGF-beta: from conception to autoimmunity and infection","volume":"9","author":"Sanjabi","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2021070723585572000_keaa701-B50","doi-asserted-by":"crossref","first-page":"e39750","DOI":"10.1371\/journal.pone.0039750","article-title":"Marking and quantifying IL-17A-producing cells in vivo","volume":"7","author":"Price","year":"2012","journal-title":"PLoS One"},{"key":"2021070723585572000_keaa701-B51","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1136\/annrheumdis-2017-211286","article-title":"Identification of a transitional fibroblast function in very early rheumatoid arthritis","volume":"76","author":"Filer","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021070723585572000_keaa701-B52","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/08916930902831977","article-title":"Relationship between serum levels of TGF-beta1 and clinical parameters in patients with rheumatoid arthritis and Sj\u00f6gren\u2019s syndrome secondary to rheumatoid arthritis","volume":"42","author":"Mieliauskaite","year":"2009","journal-title":"Autoimmunity"},{"key":"2021070723585572000_keaa701-B53","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/nm.2050","article-title":"Synovial fibroblasts spread rheumatoid arthritis to unaffected joints","volume":"15","author":"Lefevre","year":"2009","journal-title":"Nat Med"},{"key":"2021070723585572000_keaa701-B54","doi-asserted-by":"crossref","first-page":"R222","DOI":"10.1186\/ar4423","article-title":"Collagenase-3 (MMP-13) deficiency protects C57BL\/6 mice from antibody-induced arthritis","volume":"15","author":"Singh","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2021070723585572000_keaa701-B55","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1136\/ard.2008.106021","article-title":"Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis","volume":"69","author":"Jungel","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2021070723585572000_keaa701-B56","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature03417","article-title":"ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro","volume":"434","author":"Stanton","year":"2005","journal-title":"Nature"},{"key":"2021070723585572000_keaa701-B57","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.4049\/jimmunol.169.5.2643","article-title":"The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis","volume":"169","author":"Itoh","year":"2002","journal-title":"J Immunol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/6\/2990\/38695155\/keaa701.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/6\/2990\/38695155\/keaa701.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T02:43:05Z","timestamp":1625712185000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/6\/2990\/6015905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":57,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,12,1]]},"published-print":{"date-parts":[[2021,6,18]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa701","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2020,12,1]]}}}